Skip to content
Screener

Orthofix Medical Inc. OFIX Contingent consideration fair value adjustments

Contingent consideration fair value adjustments at other companies

Globus Medical logo
Globus MedicalGMED
$9.71M+85.9%
Enovis logo
EnovisENOV
$0-100%
Artivion logo
ArtivionAORT
$7.97M+204%
Boston Scientific logo
Boston ScientificBSX
-$30M-700%
IAR
Integra LifeSciencesIART
——
CONMED logo
CONMEDCNMD
——

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M—

Valuation

See full
Market cap$417.92M-18.2%
Enterprise value$551.79M-11.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(Unaudited, U.S. Dollars, in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Amortization and impairment of acquired intangibles$2,999$3,872$6,000$22,227
Changes in fair value of contingent consideration868(763)1,618(1,373)
Total$3,867$3,109$7,618$20,854

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s contingent consideration fair value adjustments?
Orthofix Medical Inc. (OFIX) reported contingent consideration fair value adjustments of $868K in Q2 2026.
How has Orthofix Medical Inc.'s contingent consideration fair value adjustments changed year-over-year?
Orthofix Medical Inc.'s contingent consideration fair value adjustments increased by 213.8% year-over-year, from -$763K to $868K.
What is the long-term trend for Orthofix Medical Inc.'s contingent consideration fair value adjustments?
Over 3 years (2021 to 2024), Orthofix Medical Inc.'s contingent consideration fair value adjustments has grown at a 24.5% compound annual growth rate (CAGR), from -$3.58M to $6.9M.
What does contingent consideration fair value adjustments mean?
Contingent consideration fair value adjustments

Ask your AI about Orthofix Medical Inc.'s contingent consideration fair value adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude